Literature DB >> 23830843

Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.

Pornpen Srisawasdi1, Somlak Vanavanan, Mana Rochanawutanon, Prapaporn Pornsuriyasak, Visasiri Tantrakul, Khanat Kruthkul, Kazuhiko Kotani.   

Abstract

OBJECTIVE: Intermediate-density lipoprotein (IDL) and low-density lipoprotein (LDL) consist of heterogeneous particles whose subpopulations may have different atherogenic characteristics. This study investigated the associations between these subpopulations and other lipids, lipoproteins and atherosclerosis-related markers. DESIGN AND METHODS: A total of 416 subjects (124 males and 292 females, mean age: 50.8 years) were enrolled in this study. Using polyacrylamide gel electrophoresis, serum lipoproteins were separated according to their specific electrophoretic mobility based on particle size. The IDL particles were separated into three midbands (MID-A to C), and the LDL particles were separated into seven subfractions (LDL1 to 7).
RESULTS: MID-B, MID-C, LDL2 and LDL3 to 6 (as a small LDL fraction) were significantly and positively correlated with very LDL (VLDL), while MID-A and LDL1 were significantly and inversely correlated with VLDL. MID-A and LDL1 were significantly and positively correlated with high-density lipoprotein (HDL). The correlation patterns between MID-A or LDL1 and triglycerides, apolipoprotein A-I, glucose, the insulin resistance index, creatinine and the mean LDL particle size had similar trends to those between HDL and these parameters.
CONCLUSIONS: The respective subpopulations of IDL and LDL particles can vary in their ability to predict cardiovascular disease risks. These variations may partially explain why quantitative assessments using LDL-cholesterol concentrations, as typically performed in conventional practice, are not perfect predictors of cardiovascular disease. Further studies are required to determine the clinical relevance of analyzing the IDL and LDL subpopulations.
© 2013.

Entities:  

Keywords:  ApoA-I; ApoB; Atherogenic lipoprotein; Atherosclerosis; CVD; Cardiovascular disease; HDL; HDL-C; HOMA-IR; HbA1C; IDL; Intermediate-density lipoprotein; LDL; LDL-C; Lipid; Lipoprotein subpopulation; Low-density lipoprotein; MID; TC; TG; VLDL; apolipoprotein A-I; apolipoprotein B; cardiovascular disease; hemoglobin A1C; high-density lipoprotein; high-density lipoprotein cholesterol; high-sensitivity C-reactive protein; homeostasis model assessment of insulin resistance; hsCRP; intermediate-density lipoprotein; low-density lipoprotein; low-density lipoprotein cholesterol; midband: intermediate-density lipoprotein; total cholesterol; triglyceride; very-low-density lipoprotein

Mesh:

Substances:

Year:  2013        PMID: 23830843     DOI: 10.1016/j.clinbiochem.2013.06.021

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.

Authors:  Rui-Xia Xu; Sha Li; Yan Zhang; Xiao-Lin Li; Yuan-Lin Guo; Cheng-Gang Zhu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2014-12-11       Impact factor: 3.876

2.  Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

Authors:  Peter P Toth; Angelo M Patti; Dragana Nikolic; Rosaria V Giglio; Giuseppa Castellino; Teresa Biancucci; Fabiana Geraci; Sabrina David; Giuseppe Montalto; Ali Rizvi; Manfredi Rizzo
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

3.  Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy.

Authors:  Eman Al Shawaf; Ebaa Al-Ozairi; Fahad Al-Asfar; Anwar Mohammad; Shaima Al-Beloushi; Sriraman Devarajan; Fahd Al-Mulla; Jehad Abubaker; Hossein Arefanian
Journal:  J Diabetes Res       Date:  2020-08-01       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.